{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:36:30Z","timestamp":1781703390229,"version":"3.54.5"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>CD39\/NTPDase1 has emerged as an important molecule that contributes to maintain inflammatory and coagulatory homeostasis. Various studies have hypothesized the possible role of CD39 in COVID-19 pathophysiology since no confirmatory data shed light in this regard. Therefore, we aimed to quantify CD39 expression on COVID-19 patients exploring its association with severity clinical parameters and ICU admission, while unraveling the role of purinergic signaling on thromboinflammation in COVID-19 patients. We selected a prospective cohort of patients hospitalized due to severe COVID-19 pneumonia (n=75), a historical cohort of Influenza A pneumonia patients (n=18) and sex\/age-matched healthy controls (n=30). CD39 was overexpressed in COVID-19 patients\u2019 plasma and immune cell subsets and related to hypoxemia. Plasma soluble form of CD39 (sCD39) was related to length of hospital stay and independently associated with intensive care unit admission (adjusted odds ratio 1.04, 95%CI 1.0-1.08, p=0.038), with a net reclassification index of 0.229 (0.118-0.287; p=0.036). COVID-19 patients showed extracellular accumulation of adenosine nucleotides (ATP and ADP), resulting in systemic inflammation and pro-coagulant state, as a consequence of purinergic pathway dysregulation. Interestingly, we found that COVID-19 plasma caused platelet activation, which was successfully blocked by the P2Y<jats:sub>12<\/jats:sub> receptor inhibitor, ticagrelor. Therefore, sCD39 is suggested as a promising biomarker for COVID-19 severity. As a conclusion, our study indicates that CD39 overexpression in COVID-19 patients could be indicating purinergic signaling dysregulation, which might be at the basis of COVID-19 thromboinflammation disorder.<\/jats:p>","DOI":"10.3389\/fimmu.2022.847894","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:16:39Z","timestamp":1643606199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation"],"prefix":"10.3389","volume":"13","author":[{"given":"Elena","family":"D\u00edaz-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Garc\u00eda-Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Zamarr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Galera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Juan","family":"Ru\u00edz-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Sol\u00e9-Viol\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodr\u00edguez-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Van-Den-Rym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"P\u00e9rez-de-Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Nanwani-Nanwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"L\u00f3pez-Collazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Garc\u00eda-Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cubillos-Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614868","article-title":"Analysis of CD39\/ATP Diphosphohydrolase (ATPDase) Expression in Endothelial Cells, Platelets and Leukocytes","volume":"82","author":"Koziak","year":"1999","journal-title":"Thromb Haemost"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-205658","article-title":"Metabolism of Circulating ADP in the Bloodstream is Mediated via Integrated Actions of Soluble Adenylate Kinase-1 and NTPDase1\/CD39 Activities","volume":"26","author":"Yegutkin","year":"2012","journal-title":"FASEB J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2008.06793.x","article-title":"Membrane Compartments and Purinergic Signalling: The Purinome, a Complex Interplay Among Ligands, Degrading Enzymes, Receptors and Transporters","volume":"276","author":"Volonte","year":"2009","journal-title":"FEBS J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvs187","article-title":"Mechanisms of ATP Release and Signalling in the Blood Vessel Wall","volume":"95","author":"Lohman","year":"2012","journal-title":"Cardiovasc Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.immuni.2019.04.003","article-title":"Inflammasome Activation Triggers Blood Clotting and Host Death Through Pyroptosis","volume":"50","author":"Wu","year":"2019","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.5551\/jat.30940","article-title":"Tissue Factor and Atherothrombosis","volume":"22","author":"Tatsumi","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"B7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/09537104.2010.497231","article-title":"P2Y12 Receptor in Platelet Activation","volume":"22","author":"Kim","year":"2011","journal-title":"Platelets"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-0997-1","article-title":"Adenosine Signaling During Acute and Chronic Disease States","volume":"91","author":"Karmouty-Quintana","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092223","article-title":"Thrombo-Inflammation: A Focus on Ntpdase1\/CD39","volume":"10","author":"Morello","year":"2021","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11883-014-0425-1","article-title":"CD39: Interface Between Vascular Thrombosis and Inflammation","volume":"16","author":"Kanthi","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02144-2014","article-title":"NTPDase1\/CD39 and Aberrant Purinergic Signalling in the Pathogenesis of COPD","volume":"47","author":"Lazar","year":"2016","journal-title":"Eur Respir J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-021-04130-4","article-title":"Possible Role of Purinergic Signaling in COVID-19","volume":"476","author":"Franciosi","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"B13","volume-title":"WHO Coronavirus (COVID-19) Dashboard","year":"2021"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"Jama"},{"key":"B15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","article-title":"Thrombocytopathy and Endotheliopathy: Crucial Contributors to COVID-19 Thromboinflammation","volume":"18","author":"Gu","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925","article-title":"Cytokine Release Syndrome in Severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140711","article-title":"The Complement System in COVID-19: Friend and Foe","volume":"5","author":"Java","year":"2020","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: Challenges of Therapeutically Targeting Coagulation and Other Host Defense Mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14768","article-title":"Abnormal Coagulation Parameters are Associated With Poor Prognosis in Patients With Novel Coronavirus Pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 Patients in Intensive Care Unit: A Report of Thromboelastography Findings and Other Parameters of Hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2307\/2531595","article-title":"Comparing the Areas Under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5647","article-title":"A Unified Inference Procedure for a Class of Measures to Assess Improvement in Risk Prediction Systems With Survival Data","volume":"32","author":"Uno H","year":"2013","journal-title":"Stat Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081750","article-title":"Defining the CD39\/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes","volume":"9","author":"Ahmadi","year":"2020","journal-title":"Cells"},{"key":"B24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/JLB.5COVA0620-370RR","article-title":"B Cell Analysis in SARS-CoV-2 Versus Malaria: Increased Frequencies of Plasmablasts and Atypical Memory B Cells in COVID-19","volume":"109","author":"Wildner","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040915","article-title":"Crucial Role for Ecto-5'-Nucleotidase (CD73) in Vascular Leakage During Hypoxia","volume":"200","author":"Thompson","year":"2004","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030530","article-title":"SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response","volume":"10","author":"Oh","year":"2021","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.039","article-title":"Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA","volume":"147","author":"Kowalinski","year":"2011","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0197151","DOI":"10.1371\/journal.pone.0197151","article-title":"CD39 is Upregulated During Activation of Mouse and Human T Cells and Attenuates the Immune Response to Listeria Monocytogenes","volume":"13","author":"Raczkowski","year":"2018","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03257.x","article-title":"Transgenic Overexpression of CD39 Protects Against Renal Ischemia-Reperfusion and Transplant Vascular Injury","volume":"10","author":"Crikis","year":"2010","journal-title":"Am J Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.8127","article-title":"Identification of Ectonucleotidases CD39 and CD73 in Innate Protection During Acute Lung Injury","volume":"178","author":"Eckle","year":"2007","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.14.1799","article-title":"Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality: An Individual Participant Meta-Analysis","volume":"294","author":"Fibrinogen Studies","year":"2005","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2017.00040","article-title":"CD40L and Its Receptors in Atherothrombosis-An Update","volume":"4","author":"Michel","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"104779","DOI":"10.1016\/j.micpath.2021.104779","article-title":"Pronounce Expression of Tim-3 and CD39 But Not PD1 Defines CD8 T Cells in Critical Covid-19 Patients","volume":"153","author":"Shahbazi","year":"2021","journal-title":"Microb Pathog"},{"key":"B34","doi-asserted-by":"publisher","first-page":"103205","DOI":"10.1016\/j.isci.2021.103205","article-title":"Limited TCR Repertoire and ENTPD1 Dysregulation Mark Late-Stage COVID-19","volume":"24","author":"Wang","year":"2021","journal-title":"iScience"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00146.2020","article-title":"Consideration of Pannexin 1 Channels in COVID-19 Pathology and Treatment","volume":"319","author":"Swayne","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 Purinergic Signalling in the Tumour Microenvironment","volume":"18","author":"Di Virgilio","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2019.05.003","article-title":"Editorial Overview: Purinergic P2X Receptors in Innate Immunity and Inflammation","volume":"47","author":"Di Virgilio","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1038\/s41467-019-10626-x","article-title":"P2X7 Receptor Induces Mitochondrial Failure in Monocytes and Compromises NLRP3 Inflammasome Activation During Sepsis","volume":"10","author":"Martinez-Garcia","year":"2019","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are Activated in Response to SARS-CoV-2 Infection and are Associated With COVID-19 Severity in Patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"108468","DOI":"10.1016\/j.clim.2020.108468","article-title":"Can Ticagrelor be Used to Prevent Sepsis-Induced Coagulopathy in COVID-19","volume":"216","author":"Omarjee","year":"2020","journal-title":"Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.05.005","article-title":"Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia","volume":"3","author":"Sexton","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower Mortality Following Pulmonary Adverse Events and Sepsis With Ticagrelor Compared to Clopidogrel in the PLATO Study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.847894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:16:43Z","timestamp":1643606203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.847894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2022.847894"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.847894","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"article-number":"847894"}}